Gender-based issues in interventional cardiology: a consensus statement from the Women in Innovations (WIN) Initiative.
Cardiovascular disease (CVD) is the leading cause of mortality in women, yet studies have suggested that it is often under-recognized. Of particular concern is the apparent suboptimal treatment of women in comparison to men, with less revascularization and use of evidence-based medications. The Women in Innovations group of cardiologists aims to highlight these issues and change perceptions to optimize the treatment of female patients with CVD, to support future research, and to encourage and guide the training of female interventional cardiologists.
Chieffo
Alaide
A
San Raffaele Scientific Institute, Invasive Cardiology Unit, Milan, Italy.
Hoye
Angela
A
Mauri
Fina
F
Mikhail
Ghada W
GW
Ammerer
Michelle
M
Grines
Cindy
C
Grinfeld
Liliana
L
Madan
Mina
M
Presbitero
Patrizia
P
Skelding
Kimberly A
KA
Weiner
Bonnie H
BH
Mehran
Roxana
R
D002309:Cardiology / Q000193:education; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000378:metabolism / Q000401:mortality / Q000628:therapy*; D002321:Career Choice; D004501:Education, Medical; D019317:Evidence-Based Medicine; D005260:Female; D012739:Gonadal Steroid Hormones / Q000378:metabolism; D054625:Healthcare Disparities; D006801:Humans; D008297:Male; D008611:Mentors; D009204:Myocardial Revascularization / Q000009:adverse effects / Q000193:education; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D012737:Sex Factors; D016896:Treatment Outcome; D016387:Women's Health
D012739:Gonadal Steroid Hormones